Delivery Order SPE2DB20D9127-SPE2DB23FPPT1
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $34,039.68 firm fixed-price contract is for the supply of 4566210981 PERJETA 420 MG/14 ML VIAL 14ML, a specialized oncology medication. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery...
- This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,254.96 contract was awarded by the Defense Logistics Agency (DLA) to provide 4566357358 PERJETA 420 MG/14 ML VIAL 14ML, a specialized oncology medication. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, which allows the agency to issue...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,756.60 contract covers the delivery of 4556522685 - PERJETA 420 MG/14 ML VIAL 14ML, a specialized oncology medication, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $25,529.76, is for the delivery of 4563651600 - PERJETA 420 MG/14 ML VIAL 14ML. This delivery order is issued under DMS Pharmaceutical Group's broader indefinite delivery contract (IDC) with the DLA, contract 4600082013 under the SPE2DB program, valued up to $4,999,999 through 2025. The IDC...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $34,039.68 and has an ultimate completion date of July 19, 2024. The contract is for the delivery of the pharmaceutical product PERJETA 420 MG/14 ML VIAL 14ML, with no set-aside designation. DMS Pharmaceutical Group Inc. holds a significant indefinite...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,254.96 firm fixed-price contract is for the procurement of PERJETA 420 MG/14 ML VIAL 14ML, a specialty oncology drug. The contract is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB...
- The U.S. Department of Defense, through the Defense Logistics Agency (DLA), awarded a firm fixed-price delivery order contract valued at $8,509.92 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4566529142 - PERJETA 420 MG/14 ML VIAL 14ML, a specialized pharmaceutical product, with a performance period through December 12, 2024. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC)...
- This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $27,343.62 contract was awarded by the Defense Logistics Agency (DLA) for the supply of PERJETA 420 MG/14 ML VIAL 14ML, a specialty oncology medication. The award is not associated with a set-aside program. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the...
- This is a firm fixed-price delivery order award by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $25,529.76, is for the delivery of a specialty oncology drug, PERJETA 420 MG/14 ML VIAL 14ML, with a period of performance through July 22, 2024. The award is part of a larger indefinite delivery contract (IDC) vehicle, SPE2DB, held by DMS Pharmaceutical Group with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $25,529.76 firm fixed-price delivery order is for the supply of PERJETA 420 MG/14 ML VIAL 14ML, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS...
- SPE2DB20D9127Indefinite Delivery Contract
- SPE2DB20D9127-SPE2DB23FPPT1Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $24,831.00 firm fixed-price contract is for the delivery of 4559643130 - PERJETA 420 MG/14 ML VIAL 14ML, a specialized oncology medication. The award is issued under a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA to issue delivery orders for a comprehensive range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards across various medical product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.8k | 1/17/23 |